{"product_id":"9783319861876","title":"Current Topics in Behavioral Neurosciences","description":"\u003ch1\u003eCurrent Topics in Behavioral Neurosciences\u003c\/h1\u003e \u003ch2\u003eLawrence, Andrew J; de Lecea, Luis\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis issue of \u003ci\u003eCurrent Topics in Behavioral Neuroscience\u003c\/i\u003e focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin\/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians.\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2018-08-02\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9783319861876\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-3-319-57535-3\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 322\u003c\/p\u003e ","brand":"Springer International Publishing","offers":[{"title":"Default Title","offer_id":44450668281996,"sku":"9783319861876","price":197.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783319861876.jpg?v=1776459413","url":"https:\/\/lateknightbooks.com\/products\/9783319861876","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}